T.K. Murphy

942 total citations
24 papers, 711 citations indexed

About

T.K. Murphy is a scholar working on Physiology, Pharmacology and Cognitive Neuroscience. According to data from OpenAlex, T.K. Murphy has authored 24 papers receiving a total of 711 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Physiology, 10 papers in Pharmacology and 5 papers in Cognitive Neuroscience. Recurrent topics in T.K. Murphy's work include Pain Mechanisms and Treatments (10 papers), Musculoskeletal pain and rehabilitation (5 papers) and Pain Management and Placebo Effect (5 papers). T.K. Murphy is often cited by papers focused on Pain Mechanisms and Treatments (10 papers), Musculoskeletal pain and rehabilitation (5 papers) and Pain Management and Placebo Effect (5 papers). T.K. Murphy collaborates with scholars based in United States, United Kingdom and Netherlands. T.K. Murphy's co-authors include Birol Emir, Robert van Seventer, Remo Panaccione, Luana Colloca, Ed Whalen, Thomas Roth, Roy Freeman, Paul Glue, Giovanni Schifitto and David M. Simpson and has published in prestigious journals such as Neurology, American Journal of Respiratory and Critical Care Medicine and American Journal of Epidemiology.

In The Last Decade

T.K. Murphy

24 papers receiving 688 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
T.K. Murphy United States 12 337 161 149 119 118 24 711
Weihua Meng United Kingdom 17 228 0.7× 88 0.5× 128 0.9× 65 0.5× 33 0.3× 44 1.0k
Jan Dobrogowski Poland 19 287 0.9× 78 0.5× 203 1.4× 271 2.3× 244 2.1× 74 841
Bernhard Frank United Kingdom 13 265 0.8× 115 0.7× 308 2.1× 147 1.2× 91 0.8× 34 879
Claus Madsen Denmark 9 265 0.8× 209 1.3× 63 0.4× 57 0.5× 94 0.8× 13 560
Dominique Lossignol Belgium 16 185 0.5× 34 0.2× 578 3.9× 147 1.2× 179 1.5× 41 1.3k
Michael A. Ueberall Germany 12 136 0.4× 72 0.4× 134 0.9× 79 0.7× 57 0.5× 28 588
Shoshana Daniel United States 12 172 0.5× 80 0.5× 186 1.2× 99 0.8× 76 0.6× 19 579
Vibol Chhor France 15 112 0.3× 162 1.0× 38 0.3× 153 1.3× 63 0.5× 25 1.4k
Henning Cuhls Germany 14 208 0.6× 94 0.6× 153 1.0× 65 0.5× 54 0.5× 35 815
Catherine Urch United Kingdom 17 363 1.1× 32 0.2× 72 0.5× 196 1.6× 240 2.0× 42 873

Countries citing papers authored by T.K. Murphy

Since Specialization
Citations

This map shows the geographic impact of T.K. Murphy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T.K. Murphy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T.K. Murphy more than expected).

Fields of papers citing papers by T.K. Murphy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T.K. Murphy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T.K. Murphy. The network helps show where T.K. Murphy may publish in the future.

Co-authorship network of co-authors of T.K. Murphy

This figure shows the co-authorship network connecting the top 25 collaborators of T.K. Murphy. A scholar is included among the top collaborators of T.K. Murphy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T.K. Murphy. T.K. Murphy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Colloca, Luana, Remo Panaccione, & T.K. Murphy. (2019). The Clinical Implications of Nocebo Effects for Biosimilar Therapy. Frontiers in Pharmacology. 10. 1372–1372. 72 indexed citations
3.
Pauer, L., Gary Atkinson, T.K. Murphy, Danielle Petersel, & Bernhardt Zeiher. (2012). Long-term Maintenance of Response Across Multiple Fibromyalgia Symptom Domains in a Randomized Withdrawal Study of Pregabalin. Clinical Journal of Pain. 28(7). 609–614. 11 indexed citations
4.
Arnold, Lesley M., Birol Emir, T.K. Murphy, et al.. (2012). Safety Profile and Tolerability of Up to 1 Year of Pregabalin Treatment in 3 Open-Label Extension Studies in Patients With Fibromyalgia. Clinical Therapeutics. 34(5). 1092–1102. 21 indexed citations
5.
Cabrera, Javier, Birol Emir, Diana Dills, et al.. (2012). Characterizing and understanding body weight patterns in patients treated with pregabalin. Current Medical Research and Opinion. 28(6). 1027–1037. 30 indexed citations
6.
Mackey, Sean, Ian Carroll, Birol Emir, et al.. (2011). Sensory Pain Qualities in Neuropathic Pain. Journal of Pain. 13(1). 58–63. 14 indexed citations
7.
8.
Seventer, Robert van, et al.. (2010). Pregabalin in the treatment of post‐traumatic peripheral neuropathic pain: a randomized double‐blind trial. European Journal of Neurology. 17(8). 1082–1089. 89 indexed citations
9.
Roth, Thomas, Robert van Seventer, & T.K. Murphy. (2010). The effect of pregabalin on pain-related sleep interference in diabetic peripheral neuropathy or postherpetic neuralgia: a review of nine clinical trials. Current Medical Research and Opinion. 26(10). 2411–2419. 52 indexed citations
10.
Emir, Birol, T.K. Murphy, Danielle Petersel, & Ed Whalen. (2010). Treatment response to pregabalin in fibromyalgia pain: effect of patient baseline characteristics. Expert Opinion on Pharmacotherapy. 11(14). 2275–2280. 5 indexed citations
11.
Simpson, David M., Giovanni Schifitto, David B. Clifford, et al.. (2010). Pregabalin for painful HIV neuropathy. Neurology. 74(5). 413–420. 151 indexed citations
12.
Tuchman, Michael, et al.. (2008). (293) Central sensitization, chronic pain syndromes, and pregabalin. Journal of Pain. 9(4). 49–49. 1 indexed citations
13.
Murphy, T.K., et al.. (2008). Efficacy of Pregabalin and Venlafaxine-XR in generalized anxiety disorder: Results of a double-blind, placebo-controlled 8-week trial. European Psychiatry. 23. S215–S215. 7 indexed citations
14.
Murphy, T.K., Philip J. Siddall, & T. Griesing. (2007). 304 EFFICACY, BY BASELINE SEVERITY OF ANXIETY SYMPTOMS, OF PREGABALIN FOR TREATING CENTRAL NEUROPATHIC PAIN IN PATIENTS WITH SPINAL CORD INJURY (SCI). European Journal of Pain. 11(S1). 1 indexed citations
15.
Rosenstock, Julio, Joseph C. Arezzo, L. LaMoreaux, et al.. (2007). 290 EFFICACY AND SAFETY OF PREGABALIN AS TREATMENT OF PAINFUL DIABETIC PERIPHERAL NEUROPATHY (DPN): A 13‐WEEK RANDOMIZED CONTROLLED TRIAL AND 6‐MONTH SAFETY EXTENSION. European Journal of Pain. 11(S1). 1 indexed citations
16.
Rowbotham, Michael C., Brett R. Stacey, Kem F. Phillips, et al.. (2007). 258 A DOUBLE‐BLIND, RANDOMIZED, PLACEBO‐CONTROLLED TRIAL TO EVALUATE TIME‐TO‐ONSET OF CLINICALLY MEANINGFUL PAIN RELIEF IN POSTHERPETIC NEURALGIA (PHN) PATIENTS TREATED WITH PREGABALIN. European Journal of Pain. 11(S1). 1 indexed citations
17.
Sawnani, Hemant, et al.. (2003). The Effect of Maternal Smoking on Respiratory and Arousal Patterns in Preterm Infants during Sleep. American Journal of Respiratory and Critical Care Medicine. 169(6). 733–738. 66 indexed citations
18.
Calle, Eugenia E., T.K. Murphy, Carmen Rodríguez, M. J. Thun, & C. W. Heath. (1998). Occupation and Breast Cancer Mortality in a Prospective Cohort of US Women. American Journal of Epidemiology. 148(2). 191–197. 45 indexed citations
19.
Brown, Maria S., Hamish A. I. McArthur, Ellen L. McCormick, et al.. (1997). Production of Tuberactinamine A by Streptomyces griseoverticillatus var. tuberacticus NRRL 3482 Fed with (S)-2-Aminoethyl-L-cysteine.. The Journal of Antibiotics. 50(8). 698–700. 6 indexed citations
20.
Brown, Maria S., et al.. (1997). Selective Production of Capreomycins through Mutation and Medium Development.. The Journal of Antibiotics. 50(8). 696–697. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Weihua Meng Breakdown of academic impact, for papers by Jan Dobrogowski Breakdown of academic impact, for papers by Bernhard Frank Breakdown of academic impact, for papers by Claus Madsen Breakdown of academic impact, for papers by Dominique Lossignol Breakdown of academic impact, for papers by Michael A. Ueberall Breakdown of academic impact, for papers by Shoshana Daniel Breakdown of academic impact, for papers by Vibol Chhor Breakdown of academic impact, for papers by Henning Cuhls Breakdown of academic impact, for papers by Catherine Urch
Rankless by CCL
2026